Circumvention of Daunorubicin Resistance by a New Tamoxifen Derivative, Toremifene, in Multidrug‐resistant Cell Line

por Urasaki, Yoshimasa, Ueda, Takanori, Nakamura, Toru
Publicado 1994

Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome

por TAKAI, MIHOKO, YAMAUCHI, TAKAHIRO, FUJITA, KEI, LEE, SHIN, OOKURA, MIYUKI, KISHI, SHINJI, URASAKI, YOSHIMASA, YOSHIDA, AKIRA, IWASAKI, HIROMICHI, UEDA, TAKANORI
Publicado 2014

Monitoring of Intracellular l‐βD‐Arabinofuranosylcytosine 5′‐Triphosphate in 1‐β‐D‐Arabinofuranosylcytosine Therapy at Low and Conventional Doses

por Yamauchi, Takahiro, Kawai, Yasukazu, Kishi, Shinji, Goto, Nobuyuki, Urasaki, Yoshimasa, Imamura, Shin, Fukushima, Toshihiro, Yoshida, Akira, Iwasaki, Hiromichi, Tsutani, Hiroshi, Masada, Mikio, Ueda, Takanori
Publicado 2001

Close Correlation of 1‐β‐D‐Arabinofuranosylcytosine 5′‐Triphosphate, an Intracellular Active Metabolite, to the Therapeutic Efficacy of N(4)‐Behenoyl‐1‐β‐D‐arabinofuranosylcytosine...

por Yamauchi, Takahiro, Kawai, Yasukazu, Goto, Nobuyuki, Kishi, Shinji, Imamura, Shin, Yoshida, Akira, Urasaki, Yoshimasa, Fukushima, Toshihiro, Iwasaki, Hiromichi, Tsutani, Hiroshi, Masada, Mikio, Ueda, Takanori
Publicado 2001

Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group

por Sakai, Tomoyuki, Masaki, Yasufumi, Otsuki, Nozomi, Sakamaki, Ippei, Kishi, Shinji, Miyazono, Takayoshi, Urasaki, Yoshimasa, Murakami, Jun, Satoh, Tomomi, Nakamura, Takuji, Iwao, Haruka, Nakajima, Akio, Kawanami, Takafumi, Miki, Miyuki, Fujita, Yoshimasa, Tanaka, Masao, Fukushima, Toshihiro, Okazaki, Toshiro, Ueda, Takanori
Publicado 2015